Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
28.9M
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
4.39M
-
Shares change
-
-365K
-
Total reported value, excl. options
-
$94.2M
-
Value change
-
-$7.77M
-
Number of buys
-
31
-
Number of sells
-
-24
-
Price
-
$21.44
Significant Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q2 2021
67 filings reported holding HQL - abrdn Life Sciences Investors - Common Shares, $0.01 par value as of Q2 2021.
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.39M shares
of 28.9M outstanding shares and own 15.22% of the company stock.
Largest 10 shareholders include NEEDHAM INVESTMENT MANAGEMENT LLC (450K shares), Advisors Asset Management, Inc. (436K shares), MORGAN STANLEY (423K shares), WELLS FARGO & COMPANY/MN (327K shares), FLAGSHIP HARBOR ADVISORS, LLC (324K shares), LAZARD ASSET MANAGEMENT LLC (204K shares), Matisse Capital (165K shares), Cetera Investment Advisers (135K shares), OSAIC HOLDINGS, INC. (133K shares), and COHEN & STEERS, INC. (126K shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.